Study 13 of 16Follistatin-344 literatureScience translational medicineTop journal2026
Erratum for the Research Article "Follistatin gene delivery enhances muscle growth and strength in nonhuman primates".
Not reported in abstract.
Where it sits
this study against the rest of the follistatin-344 corpus3
Preclinical · this one
10
Observational
0
Open-label
2
Randomised
1
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Follistatin-344 corpus
AEffects of Different Training Modalities on Circulating Irisin Levels in Overweight and Obesity Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Sports medicine (Auckland, N.Z.) · 2025 · n=1780 · SMD 0.62, 95% CI 0.39-0.85, p < 0.001, n=76 arms, 1721 subjects for circulating irisin increase.reviewBPlacental transcriptome analysis reveals BMI-dependent gene expression profiles in preeclampsia.Placenta · 2026 · n=132 · SERPINA3 demonstrated an estimated eight-fold increase (95% CI: 3.9-16.6) in preeclamptic pregnancies complicated by obesity.HumanCSerum-Free Expanded Hair Follicle Mesenchymal Stem Cells Promote Cartilage Repair in a Murine Full-Thickness Defect Model.Transplantation and cellular therapy · 2026 · n=4 · Significant improvement in histological cartilage repair scores relative to phosphate-buffered saline controls.AnimalBIntrafollicular activin-A, inhibin-B, and follistatin are associated with in vitro fertilization outcomes in subfertile women.Hormones (Athens, Greece) · 2023 · n=86 · Each 10 pg/mg increase in protein-normalized FF activin-A was associated with clinical pregnancy [RR (95% CI) = 0.76 (0.66-0.86), p<0.001].HumanCMultimodal characterization of sustained bioagent release from an epicardial depot for long-term biomaterial incorporation.Biomaterials · 2026 · Not reported in abstract.AnimalBBiophysical and computational characterization identifies FSTL1 as a novel binding target of doxorubicin.Computational biology and chemistry · 2026 · SNR = 5.763In vitro